Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 GlobeNewswire - Wed Aug 5, 7:30AM CDT

SCOTTSDALE, Ariz., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused...

FBIO : 2.77 (-0.72%)
DERM : 6.53 (+2.03%)
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing GlobeNewswire - Mon Jul 27, 7:00AM CDT

MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys...

FBIO : 2.77 (-0.72%)
FBIOP : 19.94 (+3.96%)
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference GlobeNewswire - Tue May 19, 3:45PM CDT

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company...

FBIO : 2.77 (-0.72%)
DERM : 6.53 (+2.03%)
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference GlobeNewswire - Mon May 18, 7:30AM CDT

MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...

FBIO : 2.77 (-0.72%)
FBIOP : 19.94 (+3.96%)
Fortress Biotech: Q1 Earnings Snapshot AP - Thu May 14, 3:50PM CDT

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 2.77 (-0.72%)
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights GlobeNewswire - Thu May 14, 3:10PM CDT

ZYCUBO ® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics closed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $205 million...

FBIO : 2.77 (-0.72%)
FBIOP : 19.94 (+3.96%)
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights GlobeNewswire - Wed May 13, 3:01PM CDT

Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million  Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash...

FBIO : 2.77 (-0.72%)
DERM : 6.53 (+2.03%)
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 GlobeNewswire - Wed May 6, 3:01PM CDT

SCOTTSDALE, Ariz., May 06, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused...

FBIO : 2.77 (-0.72%)
DERM : 6.53 (+2.03%)
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference GlobeNewswire - Mon May 4, 7:30AM CDT

MIAMI, May 04, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...

FBIO : 2.77 (-0.72%)
FBIOP : 19.94 (+3.96%)
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ GlobeNewswire - Tue Apr 21, 7:30AM CDT

SCOTTSDALE, Ariz., April 21, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical...

FBIO : 2.77 (-0.72%)
DERM : 6.53 (+2.03%)

Barchart Exclusives

The Data Center Boom Is Powering Utility Earnings. Here Is My Favorite Way to Play the Trend. Barchart - Thu Aug 6, 6:30PM CDT
Utility companies are increasingly benefiting from the AI data center boom, and here is my favorite way to gain exposure to this investment theme. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.